¨ | Preliminary Proxy Statement | |||||||||||||||||||
¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||||||||||||||||||
¨ | Definitive Proxy Statement | |||||||||||||||||||
ý | Definitive Additional Materials | |||||||||||||||||||
¨ | Soliciting Material Pursuant to § 240.14a-12 | |||||||||||||||||||
Revance Therapeutics, Inc. | ||||||||||||||||||||
(Name of Registrant as Specified in its Charter) | ||||||||||||||||||||
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) | ||||||||||||||||||||
Payment of Filing Fee (Check all boxes that apply): | ||||||||||||||||||||
ý | No fee required. | |||||||||||||||||||
¨ | Fee paid previously with preliminary materials. | |||||||||||||||||||
¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
D!
M\@'Z @,"# (4 AT")@(O C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+!
M LL"U0+@ NL"]0, PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#
MQP/3 ^ #[ /Y! 8$$P0@!"T$.P1(!%4$8P1Q!'X$C 2:!*@$M@3$!-,$X03P
M!/X%#044%]@8&!A8&)P8W!D@&
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M',P<]1T>'4<=:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@
M;""8(,0@\"$<(4@A=2&A( &YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"
M](-7@[J$'82 A..%1X6KA@Z& -CV/=**\ET_XE75N 3TNR53BG>R"LBZ\)6ET-K0H #GY!L/YI@_ATK7HI*36PW%/D$=[9%B ,SCDXY* ?B3@>]=%'&(@$4 *H P !T %5M2TN+4T\F
M90RY!PWF_^RBO):]V\ Z.=
M*LXXV&'?+L/=N@,"@#HJ*** "O _''_']/_P!=/Z"O?*\#\\?T__ %T_
MH* .J^#7WY_]U/YM7J5>3?"6_CLWF,KJF53&]@N>3ZUZ3_PD-M_SVC_[^+_C
M0!H45G_\)#;?\]H_^_B_XT?\)#;?\]H_^_B_XT :%%5K34HKS(B=7QUV,&Q^
M1JS0 4444 >9?%_1,>7?J/\ 8?\ FI_F/RKS[3-0;3I4N4^]&P;\NH_$<5[]
MK^DC5H)+5OXU(!]#U4_@:^>I8C"Q1AAE)!'N.#0!]'V=TMVBS)RKJ&'T(R*F
MKAOA/K7VNW-JQ^: \?[K